| IBD | Inflammatory bowel disease |
| AZA | Azathioprine |
| ADRs | Adverse drug reactions |
| 6-MP | 6-mercaptopurine |
| AP | Acute pancreatitis |
| AZA-AP | Azathioprine-associated acute pancreatitis |
| GI-INT | Gastrointestinal intolerance |
| 5-ASA | 5-aminosalicylic acid |
| CD | Crohn’s disease |
| UC | Ulcerative colitis |
| SD | Standard deviation |
| TNF | Tumor necrosis factor |
| OR | Odds ratio |
| IQR | Interquartile range |
| Cl | Confidence interval |
| CRP | C-reactive protein |
| NA | Not applicable |
| PSC | Primary sclerosing cholangitis |
| PPI | Proton pump inhibitor |
| H2RA | Histamine-2 receptor antagonist |
| GWAS | Genome-Wide Association Study |
| CYP450 | Cytochrome P450 |
| TPMT | Thiopurine S-methyltransferase |
| NUDT15 | Nudix Hydrolase 15 |